Table 5 Immunogenicity of an alternative versus standard schedule of PCV13 at 18 months of age

Geometric mean concentration

Geometric mean concentration ratio (primary outcome)

Proportion of participants with IgG concentration ≥ 0.35 μg/ml

Proportions risk ratio

Serotype

Alternative schedule (N = x)

Standard schedule (N = y)

Alternative vs standard schedule

Alternative schedule (N = x)

Standard schedule (N = y)

Alternative vs standard schedule

μg/ml (95% CI)

μg/ml (95% CI)

x (95% CI)

% (95% CI)

% (95% CI)

X (95% CI)